[et_pb_section fb_built=”1″ _builder_version=”4.16″ custom_padding=”0px||||false|false” global_colors_info=”{}”][et_pb_row _builder_version=”4.16″ background_size=”initial” background_position=”top_left” background_repeat=”repeat” width=”100%” custom_padding=”0px||0px||false|false” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_wc_breadcrumb _builder_version=”4.16″ global_colors_info=”{}”][\/et_pb_wc_breadcrumb][et_pb_wc_cart_notice _builder_version=”4.16″ global_colors_info=”{}”][\/et_pb_wc_cart_notice][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=”1_2,1_2″ _builder_version=”4.16″ background_size=”initial” background_position=”top_left” background_repeat=”repeat” width=”100%” custom_padding=”0px||||false|false” global_colors_info=”{}”][et_pb_column type=”1_2″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_wc_images _builder_version=”4.16″ global_colors_info=”{}”][\/et_pb_wc_images][\/et_pb_column][et_pb_column type=”1_2″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_wc_title _builder_version=”4.16″ global_colors_info=”{}”][\/et_pb_wc_title][et_pb_wc_rating _builder_version=”4.16″ global_colors_info=”{}”][\/et_pb_wc_rating][et_pb_wc_price _builder_version=”4.16″ global_colors_info=”{}”][\/et_pb_wc_price][et_pb_wc_description _builder_version=”4.16″ global_colors_info=”{}”][\/et_pb_wc_description][et_pb_wc_add_to_cart _builder_version=”4.16″ global_colors_info=”{}”][\/et_pb_wc_add_to_cart][et_pb_wc_meta _builder_version=”4.16″ global_colors_info=”{}”][\/et_pb_wc_meta][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=”4.16″ background_size=”initial” background_position=”top_left” background_repeat=”repeat” width=”100%” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_wc_tabs _builder_version=”4.16″ global_colors_info=”{}”]\t\t\t\t\t[\/et_pb_wc_tabs][et_pb_wc_upsells _builder_version=”4.16″ global_colors_info=”{}”][\/et_pb_wc_upsells][et_pb_wc_related_products _builder_version=”4.16″ global_colors_info=”{}”][\/et_pb_wc_related_products][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"
Sarclisa (isatuximab) is a medication used in combination with pomalidomide and dexamethasone or with carfilzomib and dexamethasone for the treatment of adults with relapsed refractory multiple myeloma (RRMM).<\/p>\n
Facts about isatuximab-irfc injection<\/strong><\/p>\n Disease Indications- Multiple Myeloma If you have a prescription from a Registered Medical Practitioner (RMP), IPN<\/a> in Delhi can assist you in obtaining access to genuine medication.\u00a0 Our professional will provide you with a step-by-step guide on how to legally and safely import \u201cisatuximab-irfc injection\u201d based on the information you provide.<\/strong><\/p>\n Indian Pharma Network (IPN) serves as a legitimate consultant and facilitator situated in New Delhi, India<\/a><\/strong>. With over two decades of industry experience, IPN offers extensive coverage across India, including prominent cities such as\u00a0Mumbai, Delhi, Kolkata, Bhubaneswar, Bangalore, Hyderabad, Chennai, Ahmedbad, Pune, Surat, Visakhapatnam, Jaipur, Lucknow, Nagpur, Indore, Patna, Agartala, Guwahati, Imphal, Kohima, Namchi, Noida, Ghaziabad, Ludhiana, Agra, Varanasi, Srinagar, Amritsar, Jodhpur, Chandigarh, Gurgaon, Gorakhpur, Dehradun, Jammu, Hyderabad, Thiruvananthapuram, Kochi, Coimbatore, Puducherry, Mysuru, Salem, Vellore, Tiruppur, Guntur, Goa, Kolhapur, Mumbai, Nashik,<\/strong>\u00a0and various other regions in India.<\/p>\n","protected":false},"featured_media":6339,"template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"
\nManufacturer- Sanofi
\nUsage- Intravenous
\nMedicine Approved By- European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada
\nSummary of FDA- approved use on approval date: Click Here<\/a>
\n(see Drugs@FDA for complete indication)<\/p>\nAccess the best support services globally<\/h4>\n
Approved accessible \"isatuximab-irfc injection\"?<\/a><\/h3>\r\nIn the United States it is indicated, in combination with pomalidomide and dexamethasone (video about this from ASH 2022), for the treatment of adults with multiple myeloma who have received at least two prior therapies including lenalidomide and a proteasome inhibitor. It is also indicated in combination with carfilzomib and dexamethasone, for the treatment of adults with relapsed or refractory multiple myeloma who have received one to three prior lines of therapy.\r\n\r\nIn the European Union it is indicated, in combination with pomalidomide and dexamethasone, for the treatment of adults with relapsed and refractory multiple myeloma (MM) who have received at least two prior therapies including lenalidomide and a proteasome inhibitor (PI) and have demonstrated disease progression on the last therapy.\r\n
How can 1 go about obtaining\u00a0isatuximab-irfc injection?<\/h3>\r\nIf isatuximab-irfc injection are not yet approved or available in your area, you may request its price in India under a specific brand name through IPN. For assistance and guidance, you can contact us by providing complete details. Our pharmaceutical expert will help you find a suitable and practical solution to your query. To receive comprehensive support, please call us at +91 9891 296 838 (Mr. Tarun) \/ +91 9811 747 774 (Mr. Neeraj).\r\n
Sarclisa (isatuximab) injection, for intravenous use Initial U.S. Approval: 2020<\/h5>\r\n
References<\/h3>\r\n1.\u00a0Full prescribing information [FDA]: Sarclisa (isatuximab)<\/a> [PDF]\r\nSanofi, Mar 2020\r\n\r\n2.\u00a0Multiple Myeloma<\/a>\r\nAmerican Cancer Society, cited on Oct 26, 2020\r\n\r\n3. European Commission approves Sarclisa\u00ae (isatuximab) for adults with relapsed and refractory multiple myeloma<\/a>\r\nSanofi press release, Jun 2, 2020\r\n\r\n4. FDA approval of Sarclisa (isatuximab-irfc) in combination with carfilzomib and dexamethasone for adult patients with relapsed or refractory multiple myeloma who have received one to three prior lines of therapy<\/a>\r\nFDA press release, March 31, 2021","_et_gb_content_width":""},"product_brand":[],"product_cat":[167],"product_tag":[],"class_list":{"0":"post-6525","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-multiple-myeloma","8":"first","9":"instock","10":"shipping-taxable","11":"product-type-simple"},"_links":{"self":[{"href":"https:\/\/indianpharmanetwork.co.in\/medicines\/wp-json\/wp\/v2\/product\/6525","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/indianpharmanetwork.co.in\/medicines\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/indianpharmanetwork.co.in\/medicines\/wp-json\/wp\/v2\/types\/product"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/indianpharmanetwork.co.in\/medicines\/wp-json\/wp\/v2\/media\/6339"}],"wp:attachment":[{"href":"https:\/\/indianpharmanetwork.co.in\/medicines\/wp-json\/wp\/v2\/media?parent=6525"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/indianpharmanetwork.co.in\/medicines\/wp-json\/wp\/v2\/product_brand?post=6525"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/indianpharmanetwork.co.in\/medicines\/wp-json\/wp\/v2\/product_cat?post=6525"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/indianpharmanetwork.co.in\/medicines\/wp-json\/wp\/v2\/product_tag?post=6525"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}